Z-2176-2017 Class II Terminated
FDA device recall Z-2176-2017 was initiated by AbbVie Inc. on Apr 27, 2017 and is designated Class II. The recall status is terminated (terminated Jul 9, 2019). Affected quantity: 673 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jun 7, 2017
- Initiation Date
- Apr 27, 2017
- Termination Date
- Jul 9, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 673 kits
Product description
AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.
Distribution pattern
Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
Code information
Material/List number: 629100116 Lots: 32025245, 32054247, 32265215, 32335206, 32335336
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2176-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026